Aggarwal Sumit's Insider Trades & SAST Disclosures
Aggarwal Sumit's most recent trade in Eloxx Pharmaceuticals Inc was a trade of 30,000 Common Stock done . Disclosure was reported to the exchange on Jan. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Aggarwal Sumit.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals Inc | Sumit Aggarwal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 30,000 | 199,930 (0%) | 0% | 0 | Common Stock | |
| Eloxx Pharmaceuticals Inc | Sumit Aggarwal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 30,000 | 30,000 | - | - | Restricted Stock Units | |
| Eloxx Pharmaceuticals Inc | Aggarwal Sumit | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2024 | 165,000 | 169,930 (0%) | 0% | 0 | Common Stock | |
| Eloxx Pharmaceuticals Inc | Aggarwal Sumit | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
| Eloxx Pharmaceuticals Inc | Sumit Aggarwal | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 68,700 | 68,700 | - | - | Stock Options (Right to Buy) | |
| Eloxx Pharmaceuticals Inc | Sumit Aggarwal | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 992,409 | 992,409 | - | - | Stock Options (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges